TLX · Telix Pharmaceuticals Ltd ADR
United States · RS rating 36 · As of 2026-11-03
| Price | 9.03 USD |
|---|---|
| 1-day change | -0.2% |
| RS rating (overall / 1M / 3M / 12M) | 36 / 24 / 40 / 40 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 38 / 13 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +29.6% |
| Market cap (USD) | $3.5B |